Ticker >

Mukka Proteins share price

Mukka Proteins Ltd.

NSE: MUKKA BSE: 544135 SECTOR: Consumer Food  14k   25   5

34.90
-0.04 (-0.11%)
BSE: 17 May 04:01 PM

Price Summary

Today's High

₹ 35.1

Today's Low

₹ 34.78

52 Week High

₹ 44

52 Week Low

₹ 32.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1047 Cr.

Enterprise Value

1256.64 Cr.

No. of Shares

30 Cr.

P/E

16.68

P/B

2.87

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  12.17

CASH

23.03 Cr.

DEBT

232.67 Cr.

Promoter Holding

73.33 %

EPS (TTM)

₹  2.09

Sales Growth

53.91%

ROE

38.66 %

ROCE

23.54%

Profit Growth

98.9 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year53.91%
3 Year25.02%
5 YearNA

Profit Growth

1 Year98.9%
3 Year45.35%
5 YearNA

ROE%

1 Year38.66%
3 Year24.55%
5 Year26.52%

ROCE %

1 Year23.54%
3 Year15.91%
5 Year16.92%

Debt/Equity

1.9128

Price to Cash Flow

-22.3

Interest Cover Ratio

4.6297516305422

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 73.33 0
Dec 2023 73.33 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 45.3517143400527% for the Past 3 years.
  • The company has shown a good revenue growth of 25.0205722921825% for the Past 3 years.
  • Company has been maintaining healthy ROE of 24.5453200868145% over the past 3 years.
  • Company’s PEG ratio is 0.168697902836941.
  • The company has an efficient Cash Conversion Cycle of 48.1507676151525 days.
  • The company has a high promoter holding of 73.33%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 12.0035636139541.
  • Promoter stake has increased from 0% to 73.33% in the last 1 quarter.

 Limitations

  • Company has contingent liabilities of 105.507 Cr.
  • Company has negative cash flow from operations of -46.959.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024
Net Sales 483.64 230.76
Total Expenditure 472.04 208.21
Operating Profit 11.6 22.56
Other Income 8.42 4.22
Interest 5.37 7.47
Depreciation 1.43 1.46
Exceptional Items 0 0
Profit Before Tax 13.2 17.86
Tax 4.15 -4.46
Profit After Tax 9.05 22.32
Adjusted EPS (Rs) 0.41 0.74

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 407.37 545.72 536.25 692.89 1066.4
Total Expenditure 382.63 525.66 529.39 660.37 1000.73
Operating Profit 24.74 20.07 6.86 32.52 65.67
Other Income 3.01 8.14 9.15 7.74 8.87
Interest 4.34 6.59 6.95 8.35 15.18
Depreciation 2.2 2.8 3 3.72 4.27
Exceptional Items -0.69 0 0 0 0
Profit Before Tax 20.53 18.82 6.06 28.2 55.1
Tax 5.12 5.98 1.45 8.38 15.67
Net Profit 15.41 12.84 4.61 19.82 39.42
Adjusted EPS (Rs.) 0.7 0.58 0.21 0.9 1.79

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 5.5 5.5 5.5 22 22
Total Reserves 39.8 52.03 57.36 60.29 99.64
Borrowings 14.35 9.84 6.96 3.04 0.27
Other N/C liabilities 3.19 3.5 3.51 6.25 9.46
Current liabilities 133.82 186.5 215.05 237.5 368.67
Total Liabilities 196.66 257.37 288.38 329.07 500.03
Assets
Net Block 42.31 44.04 47.59 48.3 51.08
Capital WIP 0 1.22 0 0 0
Intangible WIP 0 0 0 0 0
Investments 11.23 8.14 11.53 20.67 23.63
Loans & Advances 1.72 1.95 2.02 1.97 2.31
Other N/C Assets 0 0 1.42 1.38 1.6
Current Assets 141.4 202.02 225.82 256.75 421.42
Total Assets 196.66 257.37 288.38 329.07 500.03
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 20.53 18.82 6.06 28.2 55.1
Adjustment 4.58 3.47 3.63 5.05 7.71
Changes in Assets & Liabilities -42.15 -40.59 -7.74 -46.21 -101.09
Tax Paid -4.53 -5.76 -4.29 -2.34 -8.68
Operating Cash Flow -21.57 -24.06 -2.33 -15.3 -46.96
Investing Cash Flow -19.44 1.81 -5.41 -7.25 0.71
Financing Cash Flow 31.38 22.64 8.06 27.25 61.12
Net Cash Flow -9.64 0.38 0.31 4.7 14.87

Corporate Actions

Investors Details

PARTICULARS Dec 2023% Mar 2024%
promoters 73.33 73.33
k mohammad arif 16.13 16.13
k mohammed althaf 16.13 16.13
kalandan abdul razak 7.33 7.33
mohammed haris k 30.23 30.23
umaiyya banu 3.50 3.50
PARTICULARS Dec 2023% Mar 2024%
investors 26.67 26.67
craft emerging market fun... 1.22 1.22
elara india opportunities... 1.22 1.20
eminence global fund pcc-... 1.31 1.31
neomile growth fund - ser... 1.98 1.98
saint capital fund 1.25 1.19
zinnia global fund pcc - ... 1.20 1.19

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Mukka Proteins Stock Price Analysis and Quick Research Report. Is Mukka Proteins an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Mukka Proteins . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Mukka Proteins has a PE ratio of 16.7072995841101 which is high and comparatively overvalued .

  • Share Price: - The current share price of Mukka Proteins is Rs 34.95. One can use valuation calculators of ticker to know if Mukka Proteins share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Mukka Proteins has ROA of 9.50978405604122 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Mukka Proteins has a Current ratio of 1.14307995269457 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Mukka Proteins has a ROE of 38.6644043859477 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Mukka Proteins has a Debt to Equity ratio of 1.9128 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Mukka Proteins has reported revenue growth of 53.9064811433899 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Mukka Proteins for the current financial year is 6.15801980123742 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Mukka Proteins is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Mukka Proteins is Rs 2.0919 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Mukka Proteins in Ticker for free. Also, one can get the intrinsic value of Mukka Proteins by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Mukka Proteins
X